Autoimmunity to annexin A2 predicts mortality among hospitalised COVID-19 patients
Marisol Zuniga, Cláudia Gomes, Steven E. Carsons, Michael Bender, Paolo Cotzia, Qing Miao, David C. Lee, Ana Rodrı́guez
Abstract
<b>Levels of anti-annexin A2 antibodies at admission strongly predicted mortality among hospitalised COVID-19 patients. Given its critical protective function in the lung, annexin A2 antagonism may play an important role in the pathophysiology of COVID-19.</b>https://bit.ly/2UMPr9w
Topics & Concepts
MedicineAnnexin A2Coronavirus disease 2019 (COVID-19)PathophysiologyAnnexinAutoimmunitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antagonism2019-20 coronavirus outbreakPneumoniaLung functionAntibodyImmunologyInternal medicineVirologyLungReceptorFlow cytometryDiseaseOutbreakInfectious disease (medical specialty)S100 Proteins and AnnexinsThermal Regulation in MedicineRespiratory Support and Mechanisms